Varubi (Tesaro, Inc.)
Welcome to the PulseAid listing for the Varubi drug offered from Tesaro, Inc.. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Tesaro, Inc. |
| NON-PROPRIETARY NAME: | rolapitant |
| SUBSTANCE NAME: | ROLAPITANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, EMULSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-10-25 |
| END MARKETING DATE: | 0000-00-00 |
Varubi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Varubi from Tesaro, Inc. |
| LABELER NAME: | Tesaro, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.8(mg/mL) |
| START MARKETING DATE: | 2017-10-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69656-102_155e4cf0-6ad7-49ee-b6ab-dd5caeec578c |
| PRODUCT NDC: | 69656-102 |
| APPLICATION NUMBER: | NDA208399 |
Other ROLAPITANT Pharmaceutical Manufacturers / Labelers:
